ANTICANCER EFFECT OF CKD-602(BELOTECAN, CAMTOBELL) ON THE ORAL CANCER CELL LINES |
Yun, Pil-Young
(Department of Oral and Maxillofacial Surgery, College of Dentistry, Seoul National University)
Ok, Yong-Ju (Department of Oral and Maxillofacial Surgery, College of Dentistry, Seoul National University) Myoung, Hoon (Department of Oral and Maxillofacial Surgery, College of Dentistry, Seoul National University) Lee, Jong-Ho (Department of Oral and Maxillofacial Surgery, College of Dentistry, Seoul National University) Kim, Myung-Jin (Department of Oral and Maxillofacial Surgery, College of Dentistry, Seoul National University) |
1 | Hsiang YH, Liu LF: Identification of mammalian DNA topoisomerase I as an intracellular target of the anticancer drug camptothecin. Cancer Res 1988;48:1722-1726 |
2 | Rubin EH: DNA topoisomerase expression in tumors-a novel target for chemotherapy. Hum Pathol 2000;31:631-632 DOI PUBMED ScienceOn |
3 | Steller H: Mechanisms and genes of cellular suicide. Science 1995; 267:1445-1449 DOI PUBMED ScienceOn |
4 | Kang MR, Muller MT, Chung IK: Telomeric DNA damage by topoisomerase I. A possible mechanism for cell killing by camptothecin. J Biol Chem 2004;279:12535-12541 DOI ScienceOn |
5 | Thompson CB: Apoptosis in the pathogenesis and treatment of disease. Science 1995;267:1456-1462 DOI PUBMED ScienceOn |
6 | Madden KR, Champoux JJ: Overexpression of human topoisomerase I in baby hamster kidney cells: hypersensitivity of clonal isolates to camptothecin. Cancer Res 1992;52:525-532 |
7 | Lee JH, Lee JM, Kim JK, Ahn SK, Lee SJ, Kim MY et al: Antitumor activity of 7-[2-(N-isopropylamino)ethyl]-(20S)-camptothecin, CKD602, as a potent DNA topoisomerase I inhibitor. Arch Pharm Res 1998;21:581-590 DOI ScienceOn |
8 | Clarke PG, Clarke S: Historic apoptosis. Nature 1995;378:230 |
9 | Evan G: Cancer-a matter of life and cell death. Int J Cancer 1997; 71:709-711 DOI ScienceOn |
10 | Husain I, Mohler JL, Seigler HF, Besterman JM: Elevation of topoisomerase I messenger RNA, protein, and catalytic activity in human tumors: demonstration of tumor-type specificity and implications for cancer chemotherapy. Cancer Res 1994;54:539-546 |
11 | Wang Z, Droge P: Differential control of transcription-induced and overall DNA supercoiling by eukaryotic topoisomerases in vitro. EMBO J 1996;15:581-589 |
12 | Nagata S: Apoptosis by death factor. Cell 1997;88:355-365 DOI PUBMED ScienceOn |
13 | Takimoto CH, Wright J, Arbuck SG: Clinical applications of the camptothecins. Biochim Biophys Acta 1998;1400:107-119 DOI ScienceOn |
14 | Holden JA, Rahn MP, Jolles CJ, Vorobyev SV, Bronstein IB: Immunohistochemical detection of DNA topoisomerase I in formalin fixed, paraffin wax embedded normal tissues and in ovarian carcinomas. Mol Pathol 1997;50:247-253 DOI ScienceOn |
15 | Giovanella BC, Stehlin JS, Wall ME, Wani MC, Nicholas AW, Liu LF et al: DNA topoisomerase I-targeted chemotherapy of human colon cancer in xenografts. Science 1989;246:1046-1048 DOI PUBMED |
16 | Kim EJ, Lee RK, Suh JE, Han SS, Kim JK: Safety pharmacology of CKD-602, a novel anticancer agent. Arzneimittelforschung 2003; 53:272-279 |